Understanding Mechanisms, Biomarkers & Interventions in HER2 ADC–Induced Interstitial Lung Disease
1:30 pm - Monday 23rd February 2026
- Exploring mechanistic insights across cellular and molecular pathways driving ADC-induced interstitial lung disease in preclinical and clinical contexts
- Overviewing emerging translational biomarkers for early detection and patient risk stratification
- Intervention strategies: Exploring preventive and therapeutic approaches to mitigate pulmonary toxicity and improve clinical safety
